|4Feb 11, 7:53 PM ET

Enright William 4

4 · Vaccitech plc · Filed Feb 11, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
Enright William
DirectorChief Executive Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2022-01-03+359,605359,605 total
    Exercise: $11.12Exp: 2032-01-03Ordinary Shares (359,605 underlying)
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023.

Documents

1 file
  • 4
    tm226469-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT